MoneyWorks4Me

Zydus Lifesciences informs about disclosure

03 Mar 2025 Evaluate
Zydus Lifesciences has informed that Zydus Healthcare (‘ZHL’), a wholly owned subsidiary of the Company, has received demand Order-In-Original (‘O-I-O’) for the F.Y. 2020-21 on the issue pertaining to Input Tax Credit (‘ITC’) and determined tax liability from GST returns for F.Y. 2020-21. The details as required under regulation 30 of Listing Regulations read with SEBI Circular are enclosed.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..